ARENA PHARMACEUTICALS INC's ticker is ARNA and the CUSIP is 040047607. A total of 1 filers reported holding ARENA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $11,117,000 | +56.1% | 119,615 | 0.0% | 2.80% | +47.9% |
| Q3 2021 | $7,123,000 | -12.7% | 119,615 | 0.0% | 1.89% | +10.8% |
| Q2 2021 | $8,158,000 | +53.3% | 119,615 | +55.9% | 1.71% | +35.1% |
| Q1 2021 | $5,323,000 | -9.8% | 76,715 | -0.1% | 1.26% | -28.1% |
| Q4 2020 | $5,902,000 | +4.1% | 76,815 | +1.3% | 1.76% | -4.7% |
| Q3 2020 | $5,670,000 | -63.3% | 75,815 | -69.1% | 1.84% | -58.6% |
| Q2 2020 | $15,432,000 | +104.5% | 245,142 | +36.5% | 4.45% | +41.4% |
| Q1 2020 | $7,545,000 | +67.9% | 179,642 | +81.6% | 3.15% | +104.1% |
| Q4 2019 | $4,494,000 | +4.5% | 98,942 | +5.3% | 1.54% | -4.6% |
| Q3 2019 | $4,300,000 | -21.9% | 93,942 | 0.0% | 1.62% | -21.9% |
| Q2 2019 | $5,508,000 | +30.8% | 93,942 | 0.0% | 2.07% | +13.9% |
| Q1 2019 | $4,211,000 | +15.1% | 93,942 | 0.0% | 1.82% | -0.2% |
| Q4 2018 | $3,659,000 | -19.3% | 93,942 | -4.7% | 1.82% | -2.3% |
| Q3 2018 | $4,535,000 | +9.2% | 98,547 | +3.5% | 1.86% | -4.2% |
| Q2 2018 | $4,153,000 | -17.0% | 95,242 | -24.9% | 1.94% | -20.2% |
| Q1 2018 | $5,006,000 | +1810.7% | 126,742 | +715.1% | 2.44% | +1202.1% |
| Q2 2017 | $262,000 | – | 15,550 | – | 0.19% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 163,133 | $7,467,000 | 4.14% |
| PFM Health Sciences, LP | 2,271,536 | $103,968,000 | 3.07% |
| Partner Investment Management, L.P. | 28,877 | $1,322,000 | 2.26% |
| Atika Capital Management LLC | 181,000 | $8,284,000 | 1.74% |
| DAFNA Capital Management LLC | 93,942 | $4,300,000 | 1.62% |
| Asymmetry Capital Management, L.P. | 16,272 | $745,000 | 1.60% |
| First Light Asset Management, LLC | 190,838 | $8,735,000 | 1.32% |
| Perceptive Advisors | 953,129 | $43,624,000 | 1.18% |
| Rhenman & Partners Asset Management AB | 155,000 | $7,094,000 | 0.89% |
| Opus Point Partners Management, LLC | 9,770 | $447,000 | 0.81% |